Market by Component, Deployment Mode, and Country Outlook | Forecast 2023-2030
According to Triton’s report, the Asia-Pacific pharmaceutical supply chain management market is expected to register revenue growth with a CAGR of 8.87% during the forecasted period 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The countries examined
in the studied region include:
•
China
•
India
•
Japan
•
South Korea
•
Australia & New Zealand
•
ASEAN Countries
•
Rest of Asia-Pacific
The
region is leading the world in pharmaceutical sector growth and is seeing a
significant increase in demand for supply chain management solutions that
ensure the safe delivery of finished medicines to customers. Industry giants
such as SAP and Oracle are setting up facilities to handle the increased sales,
driving the expansion of the Asia-Pacific pharmaceutical supply chain
management market.
China holds the highest share value
in the region’s market.
Changing lifestyles and unhealthy eating habits have increased non-communicable
diseases such as diabetes and cardiovascular disease. As a result, the need for
medicines has increased significantly. Pharmaceutical companies are adding new
molecules to their product portfolios to address these emerging treatment
areas. This expansion may require the establishment of additional manufacturing
facilities and production lines, as well as the introduction of new
technologies. As a result, this would expand the existing supply chain network,
thereby boosting the pharmaceutical supply chain management market on a growth
path.
Like
China, the increased demand for pharmaceuticals in South Korea is mainly due to
the growing population and prevalence of chronic diseases. As a result, the
pharmaceutical industry is experiencing remarkable expansion to meet this
increased demand for medicines, thereby propelling the pharmaceutical supply
chain management market’s expansion.
A
transportation management system (TMS) is a technology-based logistics platform
that helps companies efficiently plan, execute, and optimize the movement of
goods. It manages inbound and outbound shipments, ensures regulatory
compliance, and handles required documentation. Moreover, it is often part of a
broader supply chain management (SCM) system, which provides regulatory
compliance data and insight into daily transportation operations and ensures
on-time deliveries. TMS simplifies shipping procedures and enables companies to
monitor transportation across multiple modes effectively.
The market’s expansion is assessed
in terms of component and deployment mode. The component section is divided
into solution and service. The solution is further branched into transportation
management system, planning and analytics, warehouse and inventory management
system, procurement and sourcing, and manufacturing execution system.
The well-known companies in the
market include Arvato Group, Tecsys Inc, McKesson Corporation, Cardinal Health Inc, Jump Technologies Inc, Infor, and
Oracle Corporation.
Cardinal Health Inc is an integrated healthcare products and
services player. It distributes various pharmaceuticals, medical equipment,
surgical devices, and consumer healthcare products. With a diverse portfolio
spanning logistics, products, business, and patient solutions, it caters to
various clients, including drug stores, hospitals, and clinical facilities. The
company’s strategic supply chain operations cover multiple regions, including
the Asia-Pacific.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2023-2030
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the pharmaceutical supply chain management market
revenue growth in the Asia-Pacific and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces
·
A
wide-ranging study of factors that will challenge the APAC pharmaceutical
supply chain management market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
BUYING IMPACT ANALYSIS
2.5.1. COMPETITIVE
PRICING
2.5.2. INTEGRATION
CAPABILITIES
2.5.3. INVENTORY
MANAGEMENT
2.5.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.5.5. SECURITY
AND DATA PRIVACY
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.7.2. IMPLEMENTATION
OF GS1 STANDARD
2.7.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.7.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.7.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.8. MARKET
CHALLENGES
2.8.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.8.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.8.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.8.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.9. MARKET
OPPORTUNITIES
2.9.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAIN
2.9.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COUNTRY OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1.1. CHINA
5.1.1.1.1. CHINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.1.2. JAPAN
5.1.1.2.1. JAPAN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.1.3. INDIA
5.1.1.3.1. INDIA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.1.4. SOUTH
KOREA
5.1.1.4.1. SOUTH
KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.1.5. ASEAN
COUNTRIES
5.1.1.5.1. ASEAN
COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.1.1.6. AUSTRALIA
& NEW ZEALAND
5.1.1.6.1. AUSTRALIA
& NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.1.1.7. REST
OF ASIA-PACIFIC
5.1.1.7.1. REST
OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 7: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 8: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 9: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 10: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 & 2030
(IN %)
FIGURE 3: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 & 2030 (IN
%)
FIGURE 4: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND ANALYTICS,
2023-2030 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND INVENTORY
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING,
2023-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC PHARMACEUTICAL
SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2030
(IN $ MILLION)
FIGURE 9: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 & 2030 (IN
%)
FIGURE 10: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030
(IN $ MILLION)
FIGURE 12: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022 &
2030 (IN %)
FIGURE 13: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $
MILLION)
FIGURE 14: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $
MILLION)
FIGURE 15: ASIA-PACIFIC
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022 &
2030 (IN %)
FIGURE 16: CHINA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: JAPAN
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: INDIA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: SOUTH KOREA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: ASEAN COUNTRIES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: AUSTRALIA & NEW
ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE
22: REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030
(IN $ MILLION)